Amanote Research
Register
Sign In
The Other Face of Chimeric Antigen Receptors
Molecular Therapy
- United States
doi 10.1038/mt.2014.58
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Gianpietro Dotti
Publisher
Elsevier BV
Related search
Engineering HIV-Specific Immunity With Chimeric Antigen Receptors
AIDS Patient Care and STDs
Environmental
Public Health
Infectious Diseases
Occupational Health
214. Design of Multifunctional Chimeric Antigen Receptors for T Cell Cancer Immunotherapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Author Correction: Anti-Bcma Chimeric Antigen Receptors With Fully Human Heavy-Chain-Only Antigen Recognition Domains
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Chimeric Antigen Receptors for T Cell Immunotherapy: Current Understanding and Future Directions
Journal of Gene Medicine
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
Clinical Cancer Research
Cancer Research
Oncology
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
Frontiers in Immunology
Allergy
Immunology
Correction: The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
Clinical Cancer Research
Cancer Research
Oncology
Systematic Testing and Specificity Mapping of Alloantigen-Specific Chimeric Antigen Receptors in T Regulatory Cells
JCI insight
Medicine
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology